Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies - Additional Information (Detail)

v3.8.0.1
Organization and Summary of Significant Accounting Policies - Additional Information (Detail)
$ in Millions
3 Months Ended
Aug. 01, 2017
Mar. 31, 2018
USD ($)
Organization And Summary Of Significant Accounting Policies [Line Items]    
Reverse stock split of common stock, description 11-for-1 reverse stock split  
Reverse stock split of common stock conversion ratio 11  
Takeda Pharmaceuticals Inc    
Organization And Summary Of Significant Accounting Policies [Line Items]    
Accounts receivable   $ 4.0
Revenue | Credit Risk    
Organization And Summary Of Significant Accounting Policies [Line Items]    
Percentage of total revenues   34.00%